IPSEN (IPN.PA) Stock Fundamental Analysis

EPA:IPN • FR0010259150

154.7 EUR
+7.1 (+4.81%)
Last: Feb 13, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

6

Taking everything into account, IPN scores 6 out of 10 in our fundamental rating. IPN was compared to 55 industry peers in the Pharmaceuticals industry. IPN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. IPN is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year IPN was profitable.
  • IPN had a positive operating cash flow in the past year.
  • Each year in the past 5 years IPN has been profitable.
  • Each year in the past 5 years IPN had a positive operating cash flow.
IPN.PA Yearly Net Income VS EBIT VS OCF VS FCFIPN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

1.2 Ratios

  • With a Return On Assets value of 6.56%, IPN perfoms like the industry average, outperforming 54.55% of the companies in the same industry.
  • IPN has a Return On Equity of 10.59%. This is comparable to the rest of the industry: IPN outperforms 50.91% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 14.89%, IPN is in the better half of the industry, outperforming 70.91% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for IPN is in line with the industry average of 14.21%.
  • The 3 year average ROIC (12.97%) for IPN is below the current ROIC(14.89%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.56%
ROE 10.59%
ROIC 14.89%
ROA(3y)9.04%
ROA(5y)10.56%
ROE(3y)14.84%
ROE(5y)18.77%
ROIC(3y)12.97%
ROIC(5y)15.34%
IPN.PA Yearly ROA, ROE, ROICIPN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20 25

1.3 Margins

  • IPN has a Profit Margin of 11.92%. This is comparable to the rest of the industry: IPN outperforms 45.45% of its industry peers.
  • IPN's Profit Margin has declined in the last couple of years.
  • With a Operating Margin value of 26.02%, IPN perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
  • IPN's Operating Margin has declined in the last couple of years.
  • The Gross Margin of IPN (83.32%) is better than 90.91% of its industry peers.
  • IPN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 26.02%
PM (TTM) 11.92%
GM 83.32%
OM growth 3Y-13.94%
OM growth 5Y-4.28%
PM growth 3Y-25.63%
PM growth 5YN/A
GM growth 3Y-0.54%
GM growth 5Y0.2%
IPN.PA Yearly Profit, Operating, Gross MarginsIPN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • IPN has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • IPN has more shares outstanding than it did 1 year ago.
  • IPN has about the same amout of shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, IPN has an improved debt to assets ratio.
IPN.PA Yearly Shares OutstandingIPN.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
IPN.PA Yearly Total Debt VS Total AssetsIPN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • An Altman-Z score of 4.98 indicates that IPN is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of IPN (4.98) is better than 70.91% of its industry peers.
  • IPN has a debt to FCF ratio of 1.46. This is a very positive value and a sign of high solvency as it would only need 1.46 years to pay back of all of its debts.
  • The Debt to FCF ratio of IPN (1.46) is better than 90.91% of its industry peers.
  • A Debt/Equity ratio of 0.20 indicates that IPN is not too dependend on debt financing.
  • IPN's Debt to Equity ratio of 0.20 is fine compared to the rest of the industry. IPN outperforms 74.55% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 1.46
Altman-Z 4.98
ROIC/WACC1.86
WACC8.01%
IPN.PA Yearly LT Debt VS Equity VS FCFIPN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

  • A Current Ratio of 1.98 indicates that IPN should not have too much problems paying its short term obligations.
  • The Current ratio of IPN (1.98) is better than 72.73% of its industry peers.
  • A Quick Ratio of 1.80 indicates that IPN should not have too much problems paying its short term obligations.
  • IPN's Quick ratio of 1.80 is amongst the best of the industry. IPN outperforms 83.64% of its industry peers.
Industry RankSector Rank
Current Ratio 1.98
Quick Ratio 1.8
IPN.PA Yearly Current Assets VS Current LiabilitesIPN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • IPN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.24%, which is quite good.
  • Measured over the past years, IPN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.79% on average per year.
  • Looking at the last year, IPN shows a quite strong growth in Revenue. The Revenue has grown by 9.45% in the last year.
  • Measured over the past years, IPN shows a small growth in Revenue. The Revenue has been growing by 5.83% on average per year.
EPS 1Y (TTM)12.24%
EPS 3Y4.15%
EPS 5Y8.79%
EPS Q2Q%44.4%
Revenue 1Y (TTM)9.45%
Revenue growth 3Y9.15%
Revenue growth 5Y5.83%
Sales Q2Q%9.67%

3.2 Future

  • IPN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.43% yearly.
  • Based on estimates for the next years, IPN will show a small growth in Revenue. The Revenue will grow by 4.42% on average per year.
EPS Next Y10.38%
EPS Next 2Y5.39%
EPS Next 3Y4.79%
EPS Next 5Y5.43%
Revenue Next Year8.8%
Revenue Next 2Y6.24%
Revenue Next 3Y6.01%
Revenue Next 5Y4.42%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
IPN.PA Yearly Revenue VS EstimatesIPN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1B 2B 3B 4B
IPN.PA Yearly EPS VS EstimatesIPN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • IPN is valuated correctly with a Price/Earnings ratio of 15.06.
  • Based on the Price/Earnings ratio, IPN is valued a bit cheaper than the industry average as 70.91% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 27.97. IPN is valued slightly cheaper when compared to this.
  • IPN is valuated correctly with a Price/Forward Earnings ratio of 13.56.
  • Based on the Price/Forward Earnings ratio, IPN is valued a bit cheaper than 78.18% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of IPN to the average of the S&P500 Index (27.96), we can say IPN is valued rather cheaply.
Industry RankSector Rank
PE 15.06
Fwd PE 13.56
IPN.PA Price Earnings VS Forward Price EarningsIPN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • 94.55% of the companies in the same industry are more expensive than IPN, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of IPN indicates a somewhat cheap valuation: IPN is cheaper than 72.73% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 21.8
EV/EBITDA 7.04
IPN.PA Per share dataIPN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • IPN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • IPN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.45
PEG (5Y)1.71
EPS Next 2Y5.39%
EPS Next 3Y4.79%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 1.03%, IPN has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 1.94, IPN has a dividend in line with its industry peers.
  • With a Dividend Yield of 1.03, IPN pays less dividend than the S&P500 average, which is at 1.79.
Industry RankSector Rank
Dividend Yield 1.03%

5.2 History

  • The dividend of IPN has a limited annual growth rate of 3.72%.
Dividend Growth(5Y)3.72%
Div Incr Years1
Div Non Decr Years4
IPN.PA Yearly Dividends per shareIPN.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • IPN pays out 25.94% of its income as dividend. This is a sustainable payout ratio.
  • IPN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP25.94%
EPS Next 2Y5.39%
EPS Next 3Y4.79%
IPN.PA Yearly Income VS Free CF VS DividendIPN.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M
IPN.PA Dividend Payout.IPN.PA Dividend Payout, showing the Payout Ratio.IPN.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

IPSEN

EPA:IPN (2/13/2026, 7:00:00 PM)

154.7

+7.1 (+4.81%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-22
Earnings (Next)02-12
Inst Owners15.35%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap12.97B
Revenue(TTM)3.76B
Net Income(TTM)448.00M
Analysts68.89
Price Target135.82 (-12.2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.03%
Yearly Dividend1.2
Dividend Growth(5Y)3.72%
DP25.94%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.97%
PT rev (3m)3.1%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.27%
EPS NY rev (3m)3.44%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.52%
Valuation
Industry RankSector Rank
PE 15.06
Fwd PE 13.56
P/S 3.45
P/FCF 21.8
P/OCF 13.27
P/B 3.07
P/tB 9.71
EV/EBITDA 7.04
EPS(TTM)10.27
EY6.64%
EPS(NY)11.41
Fwd EY7.37%
FCF(TTM)7.1
FCFY4.59%
OCF(TTM)11.65
OCFY7.53%
SpS44.86
BVpS50.46
TBVpS15.93
PEG (NY)1.45
PEG (5Y)1.71
Graham Number107.98
Profitability
Industry RankSector Rank
ROA 6.56%
ROE 10.59%
ROCE 18.08%
ROIC 14.89%
ROICexc 20.47%
ROICexgc 77.3%
OM 26.02%
PM (TTM) 11.92%
GM 83.32%
FCFM 15.82%
ROA(3y)9.04%
ROA(5y)10.56%
ROE(3y)14.84%
ROE(5y)18.77%
ROIC(3y)12.97%
ROIC(5y)15.34%
ROICexc(3y)20.33%
ROICexc(5y)25.52%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)15.75%
ROCE(5y)18.64%
ROICexgc growth 3Y-59.92%
ROICexgc growth 5Y-22.83%
ROICexc growth 3Y-29.05%
ROICexc growth 5Y-11.89%
OM growth 3Y-13.94%
OM growth 5Y-4.28%
PM growth 3Y-25.63%
PM growth 5YN/A
GM growth 3Y-0.54%
GM growth 5Y0.2%
F-Score7
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 1.46
Debt/EBITDA 0.5
Cap/Depr 55.61%
Cap/Sales 10.16%
Interest Coverage 250
Cash Conversion 58.65%
Profit Quality 132.77%
Current Ratio 1.98
Quick Ratio 1.8
Altman-Z 4.98
F-Score7
WACC8.01%
ROIC/WACC1.86
Cap/Depr(3y)131.36%
Cap/Depr(5y)124.73%
Cap/Sales(3y)11.81%
Cap/Sales(5y)11.18%
Profit Quality(3y)85.87%
Profit Quality(5y)89.99%
High Growth Momentum
Growth
EPS 1Y (TTM)12.24%
EPS 3Y4.15%
EPS 5Y8.79%
EPS Q2Q%44.4%
EPS Next Y10.38%
EPS Next 2Y5.39%
EPS Next 3Y4.79%
EPS Next 5Y5.43%
Revenue 1Y (TTM)9.45%
Revenue growth 3Y9.15%
Revenue growth 5Y5.83%
Sales Q2Q%9.67%
Revenue Next Year8.8%
Revenue Next 2Y6.24%
Revenue Next 3Y6.01%
Revenue Next 5Y4.42%
EBIT growth 1Y66.82%
EBIT growth 3Y-6.06%
EBIT growth 5Y1.3%
EBIT Next Year41.46%
EBIT Next 3Y13.73%
EBIT Next 5Y7.49%
FCF growth 1Y-23.46%
FCF growth 3Y-35.67%
FCF growth 5Y-17.46%
OCF growth 1Y-0.85%
OCF growth 3Y-0.07%
OCF growth 5Y7.84%

IPSEN / IPN.PA FAQ

What is the fundamental rating for IPN stock?

ChartMill assigns a fundamental rating of 6 / 10 to IPN.PA.


What is the valuation status of IPSEN (IPN.PA) stock?

ChartMill assigns a valuation rating of 6 / 10 to IPSEN (IPN.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for IPSEN?

IPSEN (IPN.PA) has a profitability rating of 6 / 10.


What is the financial health of IPSEN (IPN.PA) stock?

The financial health rating of IPSEN (IPN.PA) is 7 / 10.


How sustainable is the dividend of IPSEN (IPN.PA) stock?

The dividend rating of IPSEN (IPN.PA) is 4 / 10 and the dividend payout ratio is 25.94%.